These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 1966552)
1. Cytokines and human fibrosis. LeRoy EC; Trojanowska MI; Smith EA Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552 [TBL] [Abstract][Full Text] [Related]
2. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315 [TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts. Ichiki Y; Smith EA; LeRoy EC; Trojanowska M J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379 [TBL] [Abstract][Full Text] [Related]
5. Connective tissue metabolism including cytokines in scleroderma. Smith EA Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta. Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659 [TBL] [Abstract][Full Text] [Related]
7. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Yamamoto T; Eckes B; Krieg T Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980 [TBL] [Abstract][Full Text] [Related]
8. Regulation of PDGF and its receptors in fibrotic diseases. Bonner JC Cytokine Growth Factor Rev; 2004 Aug; 15(4):255-73. PubMed ID: 15207816 [TBL] [Abstract][Full Text] [Related]
9. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-alpha, platelet-derived growth factor B, and interleukin-1 beta. Li DQ; Tseng SC Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2068-80. PubMed ID: 8814146 [TBL] [Abstract][Full Text] [Related]
11. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). Chegini N Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441 [TBL] [Abstract][Full Text] [Related]
13. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts. Liu X; Sun SQ; Hassid A; Ostrom RS Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941 [TBL] [Abstract][Full Text] [Related]
14. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta. Xu WD; Leroy EC; Smith EA J Rheumatol; 1991 Feb; 18(2):241-6. PubMed ID: 2023218 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of the type II transforming growth factor-beta receptor inhibits fibroblasts proliferation and activates extracellular signal regulated kinase and c-Jun N-terminal kinase. Goldberg HJ; Huszár T; Mózes MM; Rosivall L; Mucsi I Cell Biol Int; 2002; 26(2):165-74. PubMed ID: 11846446 [TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins alpha 1 beta 1 and alpha 5 beta 1 by human dermal fibroblasts in vitro. Gailit J; Xu J; Bueller H; Clark RA J Cell Physiol; 1996 Nov; 169(2):281-9. PubMed ID: 8908195 [TBL] [Abstract][Full Text] [Related]
18. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts. McWhirter A; Colosetti P; Rubin K; Miyazono K; Black C Lab Invest; 1994 Dec; 71(6):885-94. PubMed ID: 7807970 [TBL] [Abstract][Full Text] [Related]
19. Mitogenic effect of transforming growth factor beta 1 on human fibroblasts involves the induction of platelet-derived growth factor alpha receptors. Ishikawa O; LeRoy EC; Trojanowska M J Cell Physiol; 1990 Oct; 145(1):181-6. PubMed ID: 2170429 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]